Both in Pharmaceuticals
NextCure vs Aardvark Therapeutics
Over the past year NXTC returned −39.3% and AARD returned −87.1%; their daily moves had a correlation of 0.05.
NXTC −39.3% AARD −87.1%Growth of $1, one year, split-adjusted
| Metric | NXTC | AARD |
|---|---|---|
| Price | $5.85 | $1.26 |
| Market cap | $26.8M | $27.6M |
| Today | −1.02% | +2.44% |
| 1 month | +2.9% | −75.0% |
| 6 months | −45.4% | −78.6% |
| Year to date | −58.8% | −90.4% |
| 1 year | −51.2% | −87.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.1M | $73.9M |
| Dividend yield | — | — |
| Volatility (60d) | 111.0% | 241.1% |
| Short % of float | 8.4% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).